United Therapeutics (UTHR) falls sharply after disclosing its late-stage drug for pulmonary...

|About: United Therapeutics Corpo... (UTHR)|By:, SA News Editor

United Therapeutics (UTHR) falls sharply after disclosing its late-stage drug for pulmonary arterial hypertension failed to improving walking distance for patients. The firm says it will still move forward to seek FDA approval based on an earlier positive study. Shares down 21% premarket.